EFFECT OF IGM-ENRICHED INTRAVENOUS IMMUNOGLOBULIN (PENTAGLOBIN) ON ENDOTOXEMIA AND ANTIENDOTOXIN ANTIBODIES IN BONE-MARROW TRANSPLANTATION

被引:47
作者
JACKSON, SK [1 ]
PARTON, J [1 ]
BARNES, RA [1 ]
POYNTON, CH [1 ]
FEGAN, C [1 ]
机构
[1] UNIV WALES COLL MED,DEPT HAEMATOL,CARDIFF CF4 4XN,S GLAM,WALES
关键词
ANTIBODIES; BONE MARROW TRANSPLANT; ENDOTOXIN; IMMUNOGLOBULIN; INTRAVENOUS;
D O I
10.1111/j.1365-2362.1993.tb00963.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endotoxin was measured in over 1000 plasma samples from bone marrow transplant patients in a randomized trial of the IgM-enriched intravenous immunoglobulin (IVIG) Pentaglobin. Peak endotoxaemia was significantly reduced (P=0.02) in patients receiving Pentaglobin and 70% of all pyrexias of unknown origin were associated with endotoxaemia. Gut mucosal damage, assessed by lactulose/mannitol ratios, was significantly associated (P=0.02) with endotoxaemia. Specific IgM antibody to endotoxin core-glycolipid was significantly raised (P<0.01) in patients receiving the IVIG, and the IgM fraction of Pentaglobin was found to contain most of the antiendotoxin antibody activity of the IVIG. These results, suggest a role for IgM-enriched IVIG as a prophylactic agent for the reduction of endotoxaemia and its consequences in bone marrow transplant patients.
引用
收藏
页码:540 / 545
页数:6
相关论文
共 18 条
[1]  
ALBANO EA, 1988, PEDIATR CLIN N AM, V5, P873
[2]  
ALKHATTAF AS, 1989, THESIS U WALES
[3]  
COHEN J, 1988, BONE MARROW TRANSPL, V3, P193
[4]  
COHEN J, 1987, LANCET, V3, P8
[5]  
DICHTELMULLER H, 1987, DRUG RES, V37, P1273
[6]  
FEGAN C, 1990, BONE MARROW TRANSPL, V5, P373
[7]  
FILKINS JP, 1971, J RETICULOENDOTH SOC, V9, P480
[8]   SERUM IMMUNOGLOBULINS TO ENDOTOXIN CORE GLYCOLIPID - ACUTE-LEUKEMIA AND OTHER CANCERS [J].
JACKSON, SK ;
PARTON, J ;
SHORTLAND, G ;
STARK, JM ;
THOMPSON, EN .
ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (07) :771-773
[9]  
LAW BJ, 1985, J INFECT DIS, V6, P988
[10]  
LIEHR H, 1982, ADV INTERNAL MED PED, P117